Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -988 | -4,224 | -3,392 | -1,777 | -706 |
| Depreciation Amortization | 2 | 917 | 902 | 88 | 41 |
| Accounts receivable | -133 | -34 | -69 | -26 | -52 |
| Other Working Capital | -220 | 127 | -3 | 83 | -57 |
| Other Operating Activity | 153 | 262 | 174 | 101 | 57 |
| Operating Cash Flow | $-1,185 | $-2,951 | $-2,387 | $-1,530 | $-717 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 3 | 915 | -4 | -4 | -4 |
| Other Investing Activity | 9 | 28 | 19 | 11 | 3 |
| Investing Cash Flow | $12 | $943 | $15 | $7 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -754 | -81 | -65 | -46 |
| Common Stock Issued | 1,851 | 1,880 | 1,880 | 1,880 | N/A |
| Financing Cash Flow | $1,851 | $1,126 | $1,799 | $1,815 | $-46 |
| Beginning Cash Position | 960 | 1,842 | 1,842 | 1,842 | 1,842 |
| End Cash Position | 1,638 | 960 | 1,270 | 2,134 | 1,079 |
| Net Cash Flow | $678 | $-882 | $-572 | $292 | $-763 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,185 | -2,951 | -2,387 | -1,530 | -717 |
| Capital Expenditure | -2 | -9 | -9 | -9 | -9 |
| Free Cash Flow | -1,186 | -2,960 | -2,396 | -1,540 | -726 |